HeartMind at Home: a smart, easy-to-use system for heart and brain health in people with Alzheimer’s and related dementia
Official title: A Smart Remote Monitoring System for Cardiometabolic Management in Patients with Alzheimer's and Related Dementia
Funded at Aventusoft, LLC · NIH-11319458 · Data updated 2026-11-12
A friendly, home-based monitoring system helps manage heart failure for adults with Alzheimer's-related dementia, using a wearable sensor and digital tools to support patients, caregivers, and clinicians.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aventusoft, LLC NIH-funded |
| Lab location | 1 site (Boca Raton, United States) |
| Project start | September 18, 2026 |
| Project end | September 17, 2027 |
| Funding year | 2026 |
| Award (this year) | $500,000 |
| NIH project number | 1R43AG099700-01 |
| Project ID | NIH-11319458 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults 65+ with Alzheimer’s disease or related dementias and coexisting heart failure who have a caregiver and access to home-based monitoring.
✕Less likely to help
Patients without a caregiver support system or with unstable medical conditions not suitable for home monitoring may see limited benefit.
What this research studies
This project aims to help people with Alzheimer’s and related dementias who also have heart failure by providing an integrated, home-based monitoring platform. The system combines a wearable biosensor and digital care tools to track heart and cognitive health, share real-time information with caregivers and clinicians, and support daily self-care. By tying together patient data, caregiver input, and clinician workflows, it seeks to reduce hospital readmissions and improve overall care at home. The approach emphasizes user-friendly design tailored to cognitive impairment and caregiver involvement, with FDA-registered hardware and a focus on seamless collaboration among the care team.
Why it matters
Potential benefit: If successful, this system could reduce hospital readmissions and improve quality of life for individuals with AD/ADRD and heart failure by simplifying self-care and enabling timely clinical decisions.
How similar studies have gone: Preliminary remote-monitoring efforts show potential, but the integrated, cognitively-tailored, caregiver-inclusive platform is a novel approach.
Where this research is happening
-
Aventusoft, LLC
Boca Raton, United States Active
Researchers
- Principal investigator: Kale, Kaustubh — Aventusoft, LLC
- Study coordinator: Kale, Kaustubh
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.